Shoulder Innovations, a Gran Rapids, MI-based company which specializes in shoulder replacement technology, closed $40M Series E equity funding.
The round was led by existing investor U.S. Venture Partners (USVP), with participation from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital, Aperture Venture Partners and new investors Arboretum Ventures and Sectoral Asset Management.
The company intends to use the funds to expand operations and development efforts.
Led by Rob Ball, CEO, Shoulder Innovations is a shoulder arthroplasty-focused medical device development company that designs and commercializes innovative products. Leveraging its patented InSet™ glenoid design, the company developed a shoulder replacement implant system focused on improving outcomes related to the greatest cause of anatomic shoulder replacement failure: glenoid loosening.
FinSMEs
10/03/2025